Haemonetics Corp (HAE)
75.44
-1.46
(-1.90%)
USD |
NYSE |
Dec 20, 16:00
75.37
-0.07
(-0.09%)
After-Hours: 20:00
Haemonetics Profit Margin (Quarterly): 9.79% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| ResMed Inc | 25.43% |
| Globus Medical Inc | 8.28% |
| Baxter International Inc | 5.19% |
| Abbott Laboratories | 15.48% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.51% |
| Return on Assets | 5.40% |
| Return on Invested Capital | 6.54% |
| Gross Profit Margin (Quarterly) | 54.25% |
| Operating Margin (Quarterly) | 14.96% |
| Return on Net Operating Assets | 6.81% |